CoChat

Continuation electroconvulsive therapy for relapse prevention in middle‐aged and elderly patients with intractable catatonic schizophrenia

Open access
SUZUKI, KAZUMASA, AWATA, SHUICHI, TAKANO, TAKEHISA, EBINA, YUKIO, IWASAKI, HITOSHI, MATSUOKA, HIROO · 2005 · Psychiatry and Clinical Neurosciences
Cited by 49

The DOI matches its Crossref record.

Abstract

The authors have previously studied the short‐term effect of the first acute electroconvulsive therapy (ECT) course (phase 1 study) on intractable catatonic schizophrenia and the 1‐year relapse rate after response to the acute ECT (phase 2 study) in middle‐aged and elderly patients. Results indicated that, although acute ECT has an excellent short‐term effect, the 1‐year relapse rate after response to acute ECT is high despite the use of continuation neuroleptics. In the present prospective study the effect was explored of continuation ECT with neuroleptics on the prevention of relapse after response to a second acute ECT course in the relapsed participants of the phase 2 study. The present study included seven consecutive patients >45 years of age with catatonic schizophrenia (Diagnostic and Statistical Manual of Mental Disorders (4th edn; DSM‐IV) who relapsed (despite the use of neuroleptics) within 1 year after response to the first acute ECT course, and then responded to the second acute ECT course. The patients were given continuation ECT combined with neuroleptics; four ECT sessions at weekly intervals, then four ECT sessions every 2 weeks, then three ECT sessions every 4 weeks. Clinical symptoms were evaluated by means of the Brief Psychiatric Rating Scale (BPRS) weekly for 48 weeks or until relapse. Relapse was defined as a BPRS score of at least 37 for 3 consecutive days. Three out of the seven patients (42.9%) had a sustained response to ECT during the 1‐year follow‐up period. In the seven patients the probability of relapse within 1 year under treatment with neuroleptics alone (phase 2 study) was statistically higher than that under continuation ECT combined with neuroleptics (present study). No statistical differences were seen between the phase 2 study and the present study in the severity of psychiatric symptoms, global social function, the number of acute ECT sessions or the dosage of neuroleptics. No patient experienced a severe cognitive or physical adverse effect resulting from continuation ECT. Continuation ECT with neuroleptics is an efficacious and safe treatment for maintaining a response in middle‐aged and elderly patients with intractable catatonic schizophrenia who have relapsed after a positive response to acute ECT despite the use of continuation neuroleptics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1819.2005.01402.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 49

Metadata

Authors
SUZUKI, K., AWATA, S., TAKANO, T., EBINA, Y., IWASAKI, H., & MATSUOKA, H.
Venue
Psychiatry and Clinical Neurosciences
Publisher
Wiley
Published
2005-07-19
Volume
59
Issue
4
Pages
481-489
ISSN
  • 1323-1316 (ISSN-L)
  • 1440-1819
OpenAlex
W1977509956
Cited by
49
References
0
FWCI
1.47
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Continuation electroconvulsive therapy for relapse prevention in middle‐aged and elderly patients with intractable catatonic schizophrenia. https://app.cochat.ai/papers/10.1111/j.1440-1819.2005.01402.x
The paper
SUZUKI, K., AWATA, S., TAKANO, T., EBINA, Y., IWASAKI, H., & MATSUOKA, H. (2005). Continuation electroconvulsive therapy for relapse prevention in middle‐aged and elderly patients with intractable catatonic schizophrenia. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2005.01402.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.